We’re still in the early stages of RSV season, but doctors are already worried about a rise in cases. As we head into the peak of 2025 RSV season, parents are once again facing an uptick in cases, ...

The FDA expanded the approval of the bivalent RSV prefusion F (RSVpreF) vaccine (Abrysvo) to include the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV ...

TAMPA, Fla. — 'Tis the season... for increased sickness. The winter and holiday season is typically when more people get sick, particularly with respiratory viruses such as the flu, RSV and COVID-19.

RSV vaccination in older adults significantly reduced cases of lower respiratory tract disease and deaths, with updated recommendations for high-risk groups. Nirsevimab effectively reduced ...

If you’re feeling under the weather, chances are pretty high that you have one of four popular viruses going around: influenza A (the flu), COVID-19, norovirus (the stomach flu) and respiratory ...

RSV significantly increases post-discharge cardiovascular complications in older adults, emphasizing the need for vaccination regardless of preexisting conditions. FDA-approved RSV vaccines for adults ...

Respiratory syncytial virus (RSV)–associated hospitalization rates among infants in the United States were significantly lower in the first year when prevention products were widely available, based ...

A new study included data on 36,706 individuals who were hospitalized and 37,842 who visited the ED while exhibiting RSV-like illness. The vast majority of patients in each setting tested negative for ...

Clesrovimab is a long-acting investigational monoclonal antibody against site IV of the respiratory syncytial virus (RSV) fusion protein. Data regarding the safety and efficacy of clesrovimab in ...

RSV might sound like just another cold virus, but for babies and young kids, it can turn serious fast. Here's what you need to know to spot it early, manage symptoms, and keep your tiny CEO safe. RSV ...